Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Rapid Therapeutic Science Laboratories, Inc. (RTSL) Leases (2021 - 2023)

Rapid Therapeutic Science Laboratories' Leases history spans 3 years, with the latest figure at $297619.0 for Q2 2023.

  • For Q2 2023, Leases fell 22.22% year-over-year to $297619.0; the TTM value through Jun 2023 reached $297619.0, down 22.22%, while the annual FY2022 figure was $340136.0, 20.0% down from the prior year.
  • Leases for Q2 2023 was $297619.0 at Rapid Therapeutic Science Laboratories, down from $318878.0 in the prior quarter.
  • Across five years, Leases topped out at $425171.0 in Q4 2021 and bottomed at $297619.0 in Q2 2023.
  • The 3-year median for Leases is $361395.0 (2022), against an average of $361395.0.
  • The largest annual shift saw Leases decreased 20.0% in 2022 before it dropped 22.22% in 2023.
  • A 3-year view of Leases shows it stood at $425171.0 in 2021, then decreased by 20.0% to $340136.0 in 2022, then fell by 12.5% to $297619.0 in 2023.
  • Per Business Quant, the three most recent readings for RTSL's Leases are $297619.0 (Q2 2023), $318878.0 (Q1 2023), and $340136.0 (Q4 2022).